Skip to main content
    E

    Embecta Corp (EMBC)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $6.15
    -0.10 (-1.60%)

    Market Cap: $366.02M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Embecta Corp (EMBC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Embecta (EMBC) has a market cap of $366.02M and an enterprise value of $1.61B. Its net debt of $1.24B equals 338.89% of its market cap. Its trailing P/E of 3.0x is below its 5-year median of 5.0x.

    Total Valuation

    Enterprise value is 338.89% above the market cap, as debt exceeds cash.

    Market Cap$366.02M
    Enterprise Value$1.61B
    Latest price (Nov 17, 2026)$6.15

    Key Dates

    The next earnings report is expected on Dec 1, 2026, covering the quarter ending Sep 30, 2026. The last ex-dividend date was Aug 27, 2026.

    Next Earnings DateDec 1, 2026 (expected)
    Last Earnings DateAug 7, 2026
    Last Ex-Dividend DateAug 27, 2026
    Last Payment DateSep 15, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count fell 4.50% in the quarter ended Jun 30, 2026 and shrank 0.91% a year over 2 years.

    Shares Outstanding56.66M
    Shares Change (YoY)-3.12%
    Shares Change (QoQ)-4.50%
    Share Count Growth (2Y CAGR)-0.91%

    Valuation Ratios

    The price to sales ratio is 0.3x. Its year-end P/E ranged from 3.9x to 8.2x from 2022 to 2025.

    P/E Ratio3.0x
    Forward P/E3.4x
    P/S Ratio0.3x
    Forward P/S0.3x
    P/FCF Ratio2.1x
    P/OCF Ratio2.1x
    PEG Ratio1.0

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 5.6x EBITDA and 9.7x free cash flow.

    EV / Earnings18.4x
    EV / Sales1.6x
    EV / EBITDA5.6x
    EV / EBIT7.2x
    EV / FCF9.7x

    Price Statistics

    The stock is down 56.43% over 52 weeks and trades 2.67% above its 50-day average.

    Beta (1Y)0.46
    52-Week Change-56.43%
    1-Month Change-0.97%
    3-Month Change+13.70%
    6-Month Change+113.13%
    Total Return (1Y)-54.17%
    Total Return (3Y CAGR)-25.45%
    Return vs SPY (1Y)-66.95%
    Max Drawdown (1Y)-79.68%
    Max Drawdown (3Y)-85.28%
    Sharpe Ratio (1Y)-0.79
    Correlation with SPY (1Y)0.06
    50-Day Average$5.99
    200-Day Average$6.11
    52-Week Range$2.76 to $14.33
    RSI (14 Days)47.1
    Average Volume (20 Days)828.27K

    Price chart

    Financial Position

    Current assets cover 1.68x current liabilities.

    Current Ratio1.68x
    Quick Ratio1.17x
    Debt / EBITDA5.09x
    Debt / FCF8.84x

    Returns and Efficiency

    Return on invested capital is 18.42% over the last 12 months, against a 5-year average of 33.26%.

    Return on Assets (ROA)6.92%
    Return on Invested Capital (ROIC)18.42%
    Return on Capital Employed (ROCE)26.22%
    ROA (5Y Average)18.77%
    ROIC (5Y Average)33.26%
    Asset Turnover0.84x
    Inventory Turnover2.05x
    Receivables Turnover6.19x
    Cash Conversion Cycle162 days

    Taxes

    Income tax took 30.00% of pretax income over the last 12 months.

    Income Tax (TTM)$37.50M
    Effective Tax Rate30.00%

    Scores

    EMBC has an Altman Z-Score of 1.32, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score1.32
    Altman Z ZoneDistress
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.02B over the last 12 months is down 7.60% from the 12 months before.

    Revenue$1.02B
    Revenue Growth (YoY)-7.60%
    Gross Profit$601.30M
    Operating Income$223.50M
    Pretax Income$125.00M
    Net Income$87.50M
    EBITDA$286.00M
    EBIT$221.70M
    Reported EPS (TTM)$2.04

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$214.70M
    Total Debt$1.46B
    Net Debt$1.24B
    Net Debt Per Share$21.89
    Working Capital$285.30M
    Shareholder Equity-$612.70M
    Tangible Book Value-$700.10M
    Total Assets$1.27B
    Total Liabilities$1.88B

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $9.50M of capital spending, operating cash flow left $164.60M of free cash flow.

    Operating Cash Flow$174.10M
    Capital Expenditures$9.50M
    Free Cash Flow$164.60M
    FCF Per Share$2.91
    Depreciation and Amortization$64.30M
    Dividends Paid$27.20M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 21.94%, against a 5-year average of 25.33%.

    Gross Margin59.03%
    Operating Margin21.94%
    Pretax Margin12.27%
    Net Margin8.59%
    EBITDA Margin28.07%
    EBIT Margin21.76%
    FCF Margin16.16%
    Gross Margin (5Y Average)66.46%
    Operating Margin (5Y Average)25.33%
    Net Margin (5Y Average)15.50%

    Growth

    Revenue fell 1.47% a year over 3 years, and EPS 19.84% a year.

    Revenue Growth (3Y CAGR)-1.47%
    Revenue Growth (5Y CAGR)-0.09%
    EPS Growth (3Y CAGR)-19.84%
    FCF Growth (3Y CAGR)-22.28%
    FCF Growth (5Y CAGR)-16.77%
    Operating Income Growth (3Y CAGR)-7.87%

    Revenue and profit by year

    Dividends and Yields

    EMBC pays out 20.72% of earnings as dividends.

    Dividend Per Share (Annual)$0.04
    Dividend Yield0.65%
    Payment ScheduleQuarterly
    Payout Ratio20.72%
    FCF Payout Ratio16.52%
    Earnings Yield33.33%
    FCF Yield47.24%
    Shareholder Yield7.81%

    Full dividend history

    Peer Position

    Against 6 similar companies, EMBC has the lowest P/E.

    P/E Ratio3.0x vs 24.6x median
    P/S Ratio0.3x vs 3.0x median
    ROIC18.42% vs 6.74% median
    Revenue Growth (Trailing 4 Quarters, YoY)-7.60% vs +9.82% median
    Dividend Yield0.65% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put EPS growth at 14.45% a year over the next fiscal year.

    EPS Growth Forecast (1Y CAGR)+14.45%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About EMBC

    What is EMBC's market cap?

    Embecta has a market cap of $366.02M. Its enterprise value, which adds debt and subtracts cash, is $1.61B.

    What is EMBC's P/E ratio?

    Embecta has a trailing P/E ratio of 3.0x and a forward P/E of 3.4x.

    How many shares of EMBC are outstanding?

    Embecta has 56.66M shares outstanding. The count is down 3.12% from a year earlier.

    Does EMBC pay a dividend?

    Yes. Embecta pays $0.04 a share a year, a dividend yield of 0.65%.

    How much debt does EMBC have?

    Embecta has $1.46B of total debt and $214.70M of cash and equivalents, a net debt position of $1.24B.